The American Academy of Pediatrics (AAP) guidelines recommend only supportive therapy
for hospitalised infants with viral bronchiolitis. This includes oxygen therapy for hypoxaemia …

While concerns about high-flow nasal cannula oxygen (HFNC) overuse and associated
increased use of hospital resources are rapidly spreading, a two-tiered approach in its use is …

Background The objective was to determine whether high-flow nasal cannula (HFNC), a
promising respiratory support in infant bronchiolitis, could reduce the proportion of treatment …

Aim Using a high‐flow nasal cannula (HFNC) for infant bronchiolitis is increasingly common,
but insufficiently studied. In this retrospective study, we examined the outcomes of HFNC …

Aim To obtain data on the safety and clinical impact of managing infants with bronchiolitis on
the ward with high‐flow nasal cannula (HFNC) treatment. Methods A prospective pilot study …

High-flow nasal cannula (HFNC) is frequently used in infants with acute viral bronchiolitis
outside pediatric intensive care units (PICU). A structured questionnaire was sent out to …

Background Bronchiolitis imposes the largest health care burden on non-elective paediatric
hospital admissions worldwide, with up to 15% of cases requiring admission to intensive …

Aim We aimed to describe the characteristics and outcomes of infants with bronchiolitis who
received high‐flow nasal cannula oxygen (HFNC) following a two‐tiered approach. Methods …

The proliferationof observational literature on the topic of high-flow nasal cannula (HFNC) as
a therapy for acute viral bronchiolitis is nothing short of remarkable. A brief PubMed search …

Objective The objective was to examine the safety and efficacy of high‐flow nasal cannula
(HFNC) therapy for children with bronchiolitis in a non‐tertiary paediatric setting. Methods …